These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 32259534)
1. Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2 Araújo RS; Silva MS; Santos DF; Silva GA Exp Eye Res; 2020 May; 194():108027. PubMed ID: 32259534 [TBL] [Abstract][Full Text] [Related]
2. Long-term lutein administration attenuates retinal inflammation and functional deficits in early diabetic retinopathy using the Ins2 Wang W; Tam KC; Ng TC; Goit RK; Chan KLS; Lo ACY BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32665315 [TBL] [Abstract][Full Text] [Related]
3. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. McLenachan S; Chen X; McMenamin PG; Rakoczy EP Clin Exp Ophthalmol; 2013 Aug; 41(6):582-92. PubMed ID: 23433122 [TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy. Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908 [TBL] [Abstract][Full Text] [Related]
5. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice. McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048 [TBL] [Abstract][Full Text] [Related]
6. Polyphenol Metabolite Pyrogallol- Santos DF; Pais M; Santos CN; Silva GA Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768833 [TBL] [Abstract][Full Text] [Related]
7. Retinal angiogenesis in the Ins2(Akita) mouse model of diabetic retinopathy. Han Z; Guo J; Conley SM; Naash MI Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):574-84. PubMed ID: 23221078 [TBL] [Abstract][Full Text] [Related]
8. The Ins2Akita mouse as a model of early retinal complications in diabetes. Barber AJ; Antonetti DA; Kern TS; Reiter CE; Soans RS; Krady JK; Levison SW; Gardner TW; Bronson SK Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2210-8. PubMed ID: 15914643 [TBL] [Abstract][Full Text] [Related]
9. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2 Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085 [TBL] [Abstract][Full Text] [Related]
10. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes. Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465 [TBL] [Abstract][Full Text] [Related]
11. Influence of endotoxin-mediated retinal inflammation on phenotype of diabetic retinopathy in Ins2 Akita mice. Vagaja NN; Binz N; McLenachan S; Rakoczy EP; McMenamin PG Br J Ophthalmol; 2013 Oct; 97(10):1343-50. PubMed ID: 23913246 [TBL] [Abstract][Full Text] [Related]
12. Antagonising Wnt/β-catenin signalling ameliorates lens-capsulotomy-induced retinal degeneration in a mouse model of diabetes. Hombrebueno JR; Ali IHA; Ma JX; Chen M; Xu H Diabetologia; 2018 Nov; 61(11):2433-2446. PubMed ID: 30019207 [TBL] [Abstract][Full Text] [Related]
13. Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Liu Y; Leo LF; McGregor C; Grivitishvili A; Barnstable CJ; Tombran-Tink J Mol Med; 2012 Dec; 18(1):1387-401. PubMed ID: 23019073 [TBL] [Abstract][Full Text] [Related]
14. Adipose stem cells and their paracrine factors are therapeutic for early retinal complications of diabetes in the Ins2 Elshaer SL; Evans W; Pentecost M; Lenin R; Periasamy R; Jha KA; Alli S; Gentry J; Thomas SM; Sohl N; Gangaraju R Stem Cell Res Ther; 2018 Nov; 9(1):322. PubMed ID: 30463601 [TBL] [Abstract][Full Text] [Related]
15. Novel transgenic mouse models develop retinal changes associated with early diabetic retinopathy similar to those observed in rats with diabetes mellitus. Guo C; Zhang Z; Zhang P; Makita J; Kawada H; Blessing K; Kador PF Exp Eye Res; 2014 Feb; 119():77-87. PubMed ID: 24370601 [TBL] [Abstract][Full Text] [Related]
16. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice. Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163 [TBL] [Abstract][Full Text] [Related]
17. Reduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes. Muir ER; Rentería RC; Duong TQ Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6488-94. PubMed ID: 22915034 [TBL] [Abstract][Full Text] [Related]
18. The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. Chaurasia SS; Lim RR; Parikh BH; Wey YS; Tun BB; Wong TY; Luu CD; Agrawal R; Ghosh A; Mortellaro A; Rackoczy E; Mohan RR; Barathi VA Sci Rep; 2018 Feb; 8(1):2847. PubMed ID: 29434227 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]